Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicola Carlone is active.

Publication


Featured researches published by Nicola Carlone.


Journal of Applied Microbiology | 2007

Antifungal activity of essential oils against filamentous fungi determined by broth microdilution and vapour contact methods

V. Tullio; Antonia Nostro; Narcisa Mandras; P. Dugo; Giuliana Banche; M.A. Cannatelli; Am Cuffini; V. Alonzo; Nicola Carlone

Aims:  The in vitro activity of some essential oils (EO) (thyme red, fennel, clove, pine, sage, lemon balm and lavender) against clinical and environmental fungal strains was determined.


Fungal Biology | 2010

Non-dermatophyte moulds as skin and nail foot mycosis agents: Phoma herbarum, Chaetomium globosum and Microascus cinereus

Vivian Tullio; Giuliana Banche; Valeria Allizond; Janira Roana; Narcisa Mandras; D Scalas; Michele Panzone; Ornella Cervetti; Sergio Valle; Nicola Carlone; Anna Maria Cuffini

The increased prevalence of dermatomycoses along with the wide range of organisms now recognized as potential pathogens needs accurate laboratory isolation and identification of the aetiological agents. In this report three cases of foot dermatomycoses due to filamentous fungi commonly present in the environment with ubiquitous distribution are described in immunocompetent subjects. Skin and nail samples were collected, suspended in 20% KOH solution, examined under a light microscope and cultured in Mycobiotic agar and Sabouraud dextrose agar containing chloramphenicol to detect fungal growth. Phoma herbarum, Chaetomium globosum, and Microascus cinereus were isolated and identified.


Antimicrobial Agents and Chemotherapy | 2009

In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, Italy

Narcisa Mandras; Vivian Tullio; Valeria Allizond; D Scalas; Giuliana Banche; Janira Roana; Francesca Robbiano; Giacomo Fucale; Aurelio Malabaila; Anna Maria Cuffini; Nicola Carlone

ABSTRACT The in vitro activities of fluconazole and voriconazole against 1,024 clinical isolates of Candida spp. were determined by the agar disk diffusion test using the Clinical and Laboratory Standards Institute (CLSI) M44-A guidelines. The results of this investigation demonstrated the broad-spectrum in vitro activity of voriconazole, relative to that of fluconazole, against yeasts tested, in particular fluconazole-resistant isolates, such as Candida krusei that showed high susceptibility to voriconazole. The situation in Turin, Italy, is quite similar to that of the rest of Italy, reflecting the worldwide trend.


Medical Mycology | 2008

Schizophyllum commune: an unusual of agent bronchopneumonia in an immunocompromised patient

Vivian Tullio; Narcisa Mandras; Giuliana Banche; Valeria Allizond; Ester Gaido; Janira Roana; Anna Maria Cuffini; Nicola Carlone

We report a case of bronchopneumonia due to Schizophyllum commune in an immunocompromised patient. While this fungus rarely causes disease in humans, it has been reported in association with several clinical entities and lung disorders. A 59-year-old white man with a gastric carcinoma was admitted to S. Giovanni Battista Hospital (Turin, Italy). Three days after the admission, he developed a bronchopneumonia, which was diagnosed through the use of X-ray and showed an abnormal infiltrative shadow. Samples of bronchial aspirate were collected for laboratory microbiological investigation. Direct microscopic examination of these specimens revealed the presence of numerous septate, hyaline hyphae and rare clamp connections. Sabouraud Dextrose Agar and Columbia agar plus 5% blood media inoculated with portions of the same specimens yielded, after 4-5 days of incubation at 25 degrees C and 37 degrees C, a cottony white mould. The fungus was identified on the basis of its macroscopic and microscopic morphology. The macroscopic examination of the colony showed raised, curved, fan-shaped and shell-like basidiocarps. The microscope examination revealed the presence of hyaline, septate hyphae with clamp connections and short, thin spicules. The fungal isolate was identified as S. commune. The patient was cured after therapy with intravenous fluconazole (600 mg twice daily for over six weeks).


International Journal of Antimicrobial Agents | 2010

Synergistic effect of erythromycin on polymorphonuclear cell antibacterial activity against erythromycin-resistant phenotypes of Streptococcus pyogenes

Giuliana Banche; Vivian Tullio; Valeria Allizond; Narcisa Mandras; Janira Roana; D Scalas; Fadwa El Fassi; Sergio D’Antico; Anna Maria Cuffini; Nicola Carlone

To evaluate the synergistic activity of erythromycin and human polymorphonuclear cells (PMNs) on the binomial erythromycin-resistant (ERY(R)) Streptococcus pyogenes/host, the phagocytic and bactericidal activities of PMNs against ERY(R) streptococcal strains (cMLS(B), M, and iMLS(B) A, B and C phenotypes) were assessed in the presence of the macrolide. The results showed that when erythromycin, PMNs and streptococci [both erythromycin-sensitive (ERY(S)) and ERY(R)] were simultaneously present in the culture medium, PMN phagocytic activity was similar to that of drug-free controls. In contrast, the results emphasised a significant high increase in intracellular killing by PMNs in the presence of erythromycin not only for ERY(S) streptococci but also for ERY(R)S. pyogenes with high (cMLS(B), iMLS(B) A and iMLS(B) B phenotypes) and moderate (M and iMLS(B) C phenotypes) erythromycin resistance compared with controls without drug. From literature data it emerged that, even if intracellularly concentrated, erythromycin is relatively inactive because of its instability. The results indicate that the enhanced intra-PMN streptococcal killing detected is mainly attributable to PMN bactericidal systems that synergise with intracellular erythromycin in eradicating ERY(R)S. pyogenes strains (both with high and moderate resistance). These data confirm that the antibiotic resistance detected in vitro does not always imply a failure of antimicrobial treatment.


Antimicrobial Agents and Chemotherapy | 2010

Synergy of Caspofungin with Human Polymorphonuclear Granulocytes for Killing Candida albicans

Vivian Tullio; Narcisa Mandras; D Scalas; Valeria Allizond; Giuliana Banche; Janira Roana; Deborah Greco; Franco Castagno; Anna Maria Cuffini; Nicola Carlone

ABSTRACT The influence of caspofungin on polymorphonuclear leukocyte (PMN) phagocytosis and intracellular killing of Candida albicans was investigated. Caspofungin, at all of the concentrations tested (2, 3.2, and 8 μg/ml), significantly increased intracellular killing by PMNs through its direct action on both yeast cells and PMNs, indicating the potential ability of caspofungin to synergize with phagocytes for candidal killing. Caspofungin may therefore constitute an effective therapeutic option for the treatment of invasive fungal infections, including those refractory to conventional treatment with azole agents.


Letters in Applied Microbiology | 2008

In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.

Giuliana Banche; Janira Roana; Valeria Allizond; S. Andreotti; A. Malabaila; N. Li Vigni; Narcisa Mandras; D Scalas; Vivian Tullio; Nicola Carlone; D. Savoia; E. Gaido; A. Barbui; Anna Maria Cuffini

Aims:  This study compared the in vitro activity of telithromycin with that of azithromycin against 438 Streptococcus pyogenes and 198 Streptococcus pneumoniae, isolated over the period 2005–2007 from specimens of different human origin obtained in three Piemonte Region’s hospitals.


Archive | 1993

Cell Wall Inhibitors and Bacterial Susceptibility to Phagocytosis

Annamaria Cuffini; Nicola Carlone; V. Tullio; G. Cavallo

Clinical experience has shown that the efficacy of antibiotic therapy depends not only on the direct effect exerted by the antibiotic on a given microorganism (expressed in terms of the minimum inhibitory or minimum bactericidal concentration) but also on the functional activity of the immune system of the host. The literature reports evidence suggesting that many antimicrobial drugs can modulate host defenses in various ways. It thus follows that a possible influence (both negative and positive) of antibiotics on phagocyte functions should always be tested, especially when antibiotics are given for the treatment or prophylaxis of infections in immunocompromised patients. In these cases it would be logical to employ drugs enhancing rather than depressing host defenses.


Mycopathologia Et Mycologia Applicata | 1974

Scanning and transmission electron microscopy evidence of the cytological effect of pyrrolnitrin on ‘Microsporon audouinii’ Gruby CBS 313-54 ‘in vitro’

Nicola Carlone; Silvano Scannerini

Scanning and transmission electron microscopy showed that a ceiling quantity (1.56 mcg) of antifungal antibiotic Pyrrolnitrin caused heavy damage to dermathophyteMicrosporon audouinii Gruby CBS 313-54in vitro. Suitable preparation technique made it clear that the changes involved consisted of hyphal collapse on the edge of the culture, with loss of euplasmic organelles identity and cell autolysis. The cell wall, however, was apparently undamaged. These findings fit in with the suggestion that the mode of action of the antibiotic leads to generalised lipoproteic membranes damage. They must, however, be considered as representing the result of the terminal phase of cell distress.


International Journal of Antimicrobial Agents | 2004

Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophils

Gigliola Reato; Anna Maria Cuffini; Vivian Tullio; Narcisa Mandras; Janira Roana; Giuliana Banche; Robin Foà; Nicola Carlone

Collaboration


Dive into the Nicola Carlone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge